Massive Bio and Sequence Me Now partner to expand cancer clinical trial access

Massive Bio, which uses AI to identify cancer patients eligible for clinical trials, is partnering with patient advocacy group Sequence Me Now. The collaboration will link resources on both organizations' websites to expand trial access.